Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAP Block for Pain After Endoscopic AVR
NCT04699422Completed
- Sponsor
- Jessa Hospital
- Start
- Dec 2020
- Primary completion
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of bupivacaine hydrochloride 0.75% injection in postoperative pain (2 arms), sponsored by Jessa Hospital. Primary endpoint: Cumulative opioid consumption by patient-controlled intravenous analgesia (PCIA) at 24 hours. Started Dec 2020; status: completed.
02
Drugs
bupivacaine hydrochloride 0.75% injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04699422.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04699422.